The oncogenic potential of FAK activation is well substantiated by various studies that showed a role of FAK signaling in tumorigenesis, cell cycle progression at G1 phase [41], in cancer metastasis [11,42] and the inhibition of caspase-3 mediated apoptosis [43,44,45]. This evidence concerns the gene PTK2 and cancer.